Intravesical electromotive administration of botulinum toxin type A in improving the bladder and bowel functions: Evidence for novel mechanism of action-Reference-Cited by-同舟云学术

Intravesical electromotive administration of botulinum toxin type A in improving the bladder and bowel functions: Evidence for novel mechanism of action

Published:2019-04-18 Issue:1 Volume:44 Page:89-95
ISSN:1079-0268
Container-title:The Journal of Spinal Cord Medicine
language:en
Short-container-title:The Journal of Spinal Cord Medicine

Author:

Kajbafzadeh Abdol-Mohammad¹,Ahmadi Hamed¹,Montaser-Kouhsari Laleh¹,Sabetkish Shabnam¹,Ladi-Seyedian Sanam¹,Sotoudeh Masoud²

Affiliation:

1. Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells Therapy, Children’s Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran

2. Department of pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

Neurology (clinical)

Link

https://www.tandfonline.com/doi/pdf/10.1080/10790268.2019.1603490

Reference30 articles.

1. Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: A systematic literature review

2. The management of overactive bladder

3. Trigonal versus extratrigonal botulinum toxin-A: a systematic review and meta-analysis of efficacy and adverse events

4. Botulinum Toxin for the Management of Bladder Dysfunction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the Barthel Index in Chinese nursing home residents: an item response theory analysis;Frontiers in Psychology;2024-04-30

2. Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options;Drugs & Aging;2023-03

3. Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment;Clinical Pharmacology: Advances and Applications;2021-11

4. Liposomal formulations of oxybutynin and resiniferatoxin for the treatment of urinary diseases: improvement of drug tolerance upon intravesical;Drug Delivery and Translational Research;2021-10-20